24006-92-6

Basic information

• Product Name: 4,5-DICHLORO-1,2-BENZENEDIMETHANOL
• Synonyms: 4,5-DICHLORO-1,2-BENZENEDIMETHANOL;AKOS 92358;(4,5-Dichloro-1,2-phenylene)dimethanol
• CAS NO: 24006-92-6
• Molecular Formula: C₈H₈Cl₂O₂
• Molecular Weight: 207.05
• Mol File: 24006-92-6.mol
• Article Data: 21

Chemical Properties

• Melting Point: 137-139 °C
• Boiling Point: 349.832 °C at 760 mmHg
• Flash Point: 165.373 °C
• Appearance: /
• Density: 1.468 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.611
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.30±0.10(Predicted)
• CAS DataBase Reference: 4,5-DICHLORO-1,2-BENZENEDIMETHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5-DICHLORO-1,2-BENZENEDIMETHANOL(24006-92-6)
• EPA Substance Registry System: 4,5-DICHLORO-1,2-BENZENEDIMETHANOL(24006-92-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 24006-92-6(Hazardous Substances Data)

Usage

General Description

4,5-Dichloro-1,2-benzenedimethanol is a chemical compound with the molecular formula C8H8Cl2O2. It is a white crystalline solid that is used in the production of pharmaceuticals, agrochemicals, and other organic compounds. It has antimicrobial properties and is often used as a preservative in cosmetic and personal care products. The compound is synthesized through the chlorination of 1,2-benzenedimethanol, resulting in the substitution of chlorine atoms at the 4 and 5 positions on the benzene ring. 4,5-Dichloro-1,2-benzenedimethanol is considered to be moderately toxic and should be handled with care and in accordance with safety precautions.

InChI:InChI=1/C8H8Cl2O2/c9-7-1-5(3-11)6(4-12)2-8(7)10/h1-2,11-12H,3-4H2

Upstream product

• 942-06-3 4,5-dichlorophthalic anhydride 
• 56962-08-4 4,5-dichlorophthalic acid 
• 106727-86-0 4,5-dichlorophthalic acid dimethyl ester 

Downstream Products

• 872181-18-5 (4,5-dichloro-2-methoxymethoxymethylphenyl)methanol 
• 21903-56-0 1,2-bis(bromomethyl)-4,5-dichlorobenzene 
• 1316054-11-1 (E)-4,5-dichloro-2-[(2-hydroxy-3-nitrocyclohex-2-en-1-yliden)methyl]benzaldehyde 
• 24006-91-5 5,6-dichloroisobenzofuran-1(3H)-one 
• 13209-33-1 4,5-dichlorobenzene-1,2-dicarbaldehyde 
• 872181-19-6 2-(4,5-dichloro-2-methoxymethoxymethylbenzyloxy)-6-fluorobenzonitrile 
• 1092448-42-4 2-(2-cyclobutyloxy-3-methyl-benzoylamino)-5,6-dichloro-indan-2-carboxylic acid ethyl ester 
• 1092446-91-7 2-(2-cyclobutyloxy-3-methyl-benzoylamino)-5,6-dichloro-indan-2-carboxylic acid 
• 1379772-67-4 (6,7-dichloro-3-phenylnaphthalen-2-yloxy)triisopropylsilane 
• 280134-99-8 4-formyl-1-(4,5-dichloro-2-hydroxymethylbenzyl)-indole 
• 130217-42-4 Dimethyl 2,5-Dihydro-1-benzyloxycarbonyl-2-<2-(t-butyldimethylsilyloxymethyl)-4,5-dichlorophenyl>pyrrole-3,4-dicarboxylate 
• 130217-45-7 Dimethyl 2,5-Dihydro-1-benzyloxycarbonyl-2-(2-chloromethyl-4,5-dichlorophenyl)pyrrole-3,4-dicarboxylate 
• 130217-40-2 [1-[2-(tert-Butyl-dimethyl-silanyloxymethyl)-4,5-dichloro-phenyl]-meth-(E)-ylidene]-trimethylsilanylmethyl-amine 
• 130217-38-8 2-(((tert-butyldimethylsilyl)oxy)methyl)-4,5-dichlorobenzaldehyde 

Relevant articles and documents

2,3-Dihalo- and 2,3,6,7-Tetrahaloanthracenes by Vollhardt Trimerization

We efficiently synthesized otherwise difficult to obtain 2,3- and 2,3,6,7-halogenated anthracenes with diverse east/west substituents. Key steps involve the (i) Vollhardt cyclization of bis(propargyl)benzenes with bis(trimethylsilyl)acetylene, (ii) halo-desilylation introducing chlorine, bromine, or iodine substituents, and (iii) dehydrogenation. Pd catalysis allows selective functionalization at the anthracenes' east/west positions. A tetrahydropentacene is synthesized and derivatized via the same strategy, employing tetrapropargylbenzene.

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).